B83/100
Desk Score
Dispatch #5Partner
ShedRx
Widest formulation spread on the board — oral and sublingual routes alongside standard injection.
Visit ShedRx ↗Partner — we may earn a commission, at no cost to you. It never changes the Desk Score.
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
Desk Score breakdown
Each of the six scored dimensions. See the methodology.
Price transparency83/100
State access74/100
Molecule range96/100
Onboarding speed85/100
Support responsiveness80/100
Licensing & trust85/100
What the Desk likes
- Oral and sublingual GLP-1 routes available
- Competitive tirzepatide pricing
- Strong dose flexibility
Where points come off
- States served not disclosed
- Compounded only
The Desk's briefing — B
Best for: People who want needle-free or sublingual options rather than weekly injections.
Pricing and verification reflect ShedRx's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on ShedRx's site. Not medical advice; see our disclosure.